Yahoo Web Search

  1. Ad
    related to Mallinckrodt Inc
  1. Yahoo Finance Results

  2. Wolf Popper LLP is investigating claims on behalf of investors in Sucampo Pharmaceuticals, Inc. SCMP), concerning the proposed acquisition of Sucampo by Mallinckrodt plc (MNK).

  3. Sucampo” or the “Company”) (NASDAQ GM: SCMP) stock prior to December 27, 2017...that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Sucampo to Mallinckrodt ...

  4. Mallinckrodt plc MNK entered into an agreement with Baxter International Inc. BAX wherein the former will sell certain hemostasis products to the latter for approximately $185 ...

  5. Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

    PR Newswire via Yahoo FinanceJan 08 12:45 PM

    STAINES-UPON-THAMES, United Kingdom, Jan. 8, 2018 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, announced today it has entered into an agreement ...

  6. Can Sucampo Acquisition Turn Mallinckrodt Stock Around?

    Zacks via Yahoo FinanceJan 03 12:57 PM

    We remind investors that in February 2015, Mallinckrodt along with subsidiaries had filed a suit in the U.S. District Court for the District of Delaware against Praxair, Inc. PX ...

  7. 2017 turned out to be a pretty good year for pharma and biotech stocks where FDA decisions are concerned. The regulatory body approved 46 novel drugs last year, easily surpassing 2016’s total ...

  8. "Sucampo " or the "Company") (SCMP) relating to the merger of the Company to Mallinckrodt plc. As a result of the merger Sucampo shareholders are only anticipated to receive $18.00 in ...

  9. Stock Monitor: Mallinckrodt Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free research report on Baxter International Inc. (NYSE: BAX ). ...

  10. Stocks recently featured in the blog include Synergy Pharmaceuticals Inc. SGYP, Aradigm Corporation ARDM and Sucampo Pharmaceuticals, Inc. SCMP. Today, Zacks is promoting its ' ...

  11. Trevena Announces FDA Acceptance of Olinvo NDA, Shares Up

    Zacks via Yahoo FinanceJan 03 15:03 PM

    Shares of Trevena, Inc. TRVN rallied almost 24.5% in after-market trading on Jan 2, following the company’s announcement that the FDA has accepted the new drug application (“NDA”) for ...

  1. Ads
    related to Mallinckrodt Inc